Most-used single-cell platforms ranked by how many preprints say they used each

Single-cell platforms give each cell's RNA its own barcode, so one sequencing run can read thousands to millions of cells one by one. Chromium uses droplets, Rhapsody tiny wells and Evercode ordinary lab plates. Updated daily (as of Nov 16)

10x Chromium is the most-used single-cell platform.

10x Chromium had 91% of the uses in Jun–Nov 2026, down from 95% the year before. Parse Evercode is second with 6%.

#PlatformLast 6 monthsGrowthTotalBy year
1 Chromium10x Genomics 1,044 preprints −5% 3,635 93%
2 EvercodeParse (QIAGEN) 69 preprints +113% 178 5%
3 RhapsodyBD (Waters) 31 preprints Too few to compare 97 2%

Last 6 months is Jun–Nov 2026. Growth compares it with Jun–Nov 2025, as a share of all preprints. Total counts every preprint since April 2025 that says it used the platform.

Top institutions for each platform

  1. Stanford University70
  2. University of California, San Francisco55
  3. University of Pennsylvania51
  4. Washington University in St. Louis42
  5. University of Michigan42
  1. University of California, Irvine6
  2. University of California, San Francisco6
  3. Stanford University6
  4. University of North Carolina at Chapel Hill4
  5. Icahn School of Medicine at Mount Sinai3
  1. Heinrich Heine University Düsseldorf3
  2. German Center for Neurodegenerative Diseases3
  3. Fred Hutchinson Cancer Center2
  4. University of Massachusetts Chan Medical School2
  5. The University of Tokyo2

Counts every preprint since April 2025, by the corresponding author's institution.

Parse Evercode is growing fastest.

Up 113% in Jun–Nov 2026 vs the previous year as a share of all preprints. 10x Chromium was down 5%. BD Rhapsody has too few preprints to compare. All three together shrank 1%. Compare side by side: Chromium vs Evercode →

ChromiumEvercodeRhapsody

Latest preprints using single-cell sequencing

How we count which preprints use each platform

An AI model reads each preprint in full — its text, its tables and its supplementary files — and lists the products the authors used. A preprint counts for a platform when that record says the lab used it in this work, not when it only analyzed data others made with it or only mentioned it. Each preprint counts once, by its first version, if it was first posted on bioRxiv or medRxiv in April 2025 or later. We read new preprints within days of posting, so the newest ones (through Nov 16, 2026) are already counted, but those days are not complete yet. Six-month counts and growth figures stop at Nov 12, 2026, the last day nearly every preprint has been read, and charts draw a quarter that is still being counted in a paler color. A preprint that used two platforms counts for both. Each title links to the preprint on bioRxiv or medRxiv; we show no preprint text and no author names. Updated daily, most recently on Nov 16, 2026.

Want to reach out to the labs using each product?

Get the PIs behind the preprints: institutions, labs, platforms they used, and how to reach them.

Institutions with the most preprints using these platforms